









Markets
/
Stocks
/
nasdaq-dtck
/

Davis Commodities Ltd

DTCK

0.901USD

-0.009-0.99%

Close 09/16, 16:00（ET）Quotes delayed by 15 min

22.08MMarket Cap

--P/E TTM



Davis Commodities Ltd

0.901

-0.009-0.99%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-15

Key Insights

Its valuation is considered fairly valued,and institutional recognition is very high. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

27 / 31

Overall Ranking

454 / 4724

Industry

Food & Drug Retailing

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Davis Commodities Limited is an agricultural commodity trading company. The Company specializes in the trading of three main categories of agricultural commodities, namely sugar, rice, and oil and fat products. The Company’s segments include sale of sugar, sale of rice, sale of oil and fat products, and sale of others. It distributes agricultural commodities to various markets, including Asia, Africa and the Middle East. It also provides customers with complementary, ancillary services, such as warehouse handling and storage and logistics services. It is engaged in utilizing a global network of third-party commodity suppliers and logistics service providers in order to distribute sugar, rice, and oil and fat products to customers in over 20 countries. The Company sources and markets the commodities it distributes under two main brands: Maxwill and Taffy. The Maxwill brand is used for the sugar products and oil and fat products that the Company distributes outside of Singapore.

Turnaround to Loss

The company's performance has turned to a loss, with the latest annual loss of USD 3.53M.%!(EXTRA int=2)

Overvalued

The company’s latest PE is -6.32, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 23.50M shares, decreasing 3.68% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 0.00 shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.68.

Financial Health

Currency: USD Updated：2025-09-15

There is no financial score for this company; the Food & Drug Retailing industry's average is 7.09.

Score

Industry at a Glance

Previous score

0.00

Change



Financials



Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings



Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency



Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential



Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns



Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-15

The company’s current valuation score is 1.20, which is lower than the Food & Drug Retailing industry's average of 2.64. Its current P/E ratio is -5.03, which is 29.80% below the recent high of -6.53 and -54.63% above the recent low of -7.78.

Score

Industry at a Glance

Previous score

4.00

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 27/31

No Data

Earnings Forecast

Currency: USD Updated：2025-09-15

There is no earnings forecast score for this company; the Food & Drug Retailing industry's average is 7.38.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

No Data

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-15

The company’s current price momentum score is 6.32, which is lower than the Food & Drug Retailing industry's average of 7.21. Sideways: Currently, the stock price is trading between the resistance level at 0.87 and the support level at 0.63, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.23

Change

1.32

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(2)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.022

Buy

RSI(14)

57.382

Neutral

STOCH(KDJ)(9,3,3)

45.798

Sell

ATR(14)

0.071

High Vlolatility

CCI(14)

43.747

Neutral

Williams %R

35.294

Buy

TRIX(12,20)

0.496

Sell

StochRSI(14)

66.543

Buy

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

0.902

Sell

MA10

0.913

Sell

MA20

0.832

Buy

MA50

0.862

Buy

MA100

0.772

Buy

MA200

0.848

Buy

Institutional Confidence

Currency: USD Updated：2025-09-15

The company’s current institutional recognition score is 10.00, which is higher than the Food & Drug Retailing industry's average of 7.38. The latest institutional shareholding proportion is 95.90%, representing a quarter-over-quarter increase of 0.00%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.00% of shares outstanding, with 100.00% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Whee (Ng Hong)

4.80M

Tee (Leck Yak)

2.09M

Sheng (Lek Pow)

1.46M

-34.85%

Geode Capital Management, L.L.C.

11.99K

UBS Financial Services, Inc.

13.29K

-37.58%

Davis & KT Holdings Pte Ltd

15.06M

Citadel Advisors LLC

38.02K

-16.64%

Renaissance Technologies LLC

Star Investors

23.88K

-30.02%

WealthCollab, LLC

-100.00%

Risk Assessment

Currency: USD Updated：2025-09-15

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Food & Drug Retailing domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The company’s current risk assessment score is 3.12, which is lower than the Food & Drug Retailing industry's average of 4.61. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.